Rituximab as treatment for minimal residual disease in hairy cell leukaemia

Lasting Remissions in Hairy-Cell Leukemia Induced by a Single Infusion of 2-Chlorodeoxyadenosine

1990 • 521 citations

Efficacy of the Anti-CD22 Recombinant Immunotoxin BL22 in Chemotherapy-Resistant Hairy-Cell Leukemia

2001 • 514 citations

Long-Term Follow-Up of Patients With Hairy Cell Leukemia After Cladribine Treatment

1998 • 318 citations

Levels of expression of CD19 and CD20 in chronic B cell leukaemias.

1998 • 315 citations

The mechanisms of action of rituximab in the elimination of tumor cells

2003 • 243 citations

Splenectomy in hairy cell leukemia: A retrospective multicenter analysis

1981 • 181 citations

Rituximab in relapsed or refractory hairy cell leukemia

2003 • 162 citations

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients.

1998 • 157 citations

Treatment of hairy cell leukemia with recombinant alpha 2 interferon

1985 • 157 citations

Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma

1998 • 152 citations

Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up.

1997 • 134 citations

Treatment of hairy cell leukemia with recombinant alpha 2 interferon

1985 • 134 citations

Second cancer risk in hairy cell leukemia: analysis of 350 patients.

1997 • 117 citations

Rituximab, a chimaeric anti‐CD20 monoclonal antibody, in the treatment of hairy cell leukaemia

2001 • 111 citations

Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine

1994 • 110 citations

Interferon is effective in hairy‐cell leukaemia

1985 • 108 citations

Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience

1996 • 103 citations

Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia.

2001 • 91 citations

Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine

1994 • 91 citations

Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine

1996 • 91 citations

Higher Levels of Surface CD20 Expression on Circulating Lymphocytes Compared With Bone Marrow and Lymph Nodes in B-Cell Chronic Lymphocytic Leukemia

2001 • 80 citations

Determination of B-Cell Clonality in Paraffin-Embedded Lymph Nodes Using the Polymerase Chain Reaction

1993 • 80 citations

Rituximab (IDEC-C2B8): Validation of a Sensitive Enzyme-Linked Immunoassay Applied to a Clinical Pharmacokinetic Study

2000 • 64 citations

Molecular cytogenetic characterization of non‐Hodgkin lymphoma cell lines

2001 • 60 citations

The significance of minimal residual disease in hairy cell leukaemia treated with deoxycoformycin: a long‐term follow‐up study

1997 • 57 citations

A single course of 2-chloro-deoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission.

1994 • 54 citations

Assessment of Clonality in Cutaneous Lymphoid Infiltrates by Polymerase Chain Reaction Analysis of Immunoglobulin Heavy Chain Gene Rearrangement

1997 • 49 citations

Guidelines for the treatment of hairy cell leukemia.

1987 • 46 citations

The Scripps Clinic experience with 2-chlorodeoxyadenosine in the treatment of hairy cell leukemia.

1994 • 46 citations

Overview of non-Hodgkin's lymphoma: Biology, staging, and treatment

2003 • 45 citations

Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.

1999 • 42 citations

Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group B.

1995 • 35 citations

An advantageous method to evaluate IgH rearrangement and its role in minimal residual disease detection

1999 • 32 citations

Integrated genetic and physical map of the 1q31→q32.1 region, encompassing the RP12 locus, the F13B and HF1 genes, and the EEF1AL11 and RPL30 pseudogenes

1999 • 30 citations

Immunobiological treatments of hairy-cell leukaemia

2003 • 21 citations

Rituximab: a useful drug for a repeatedly relapsed hairy cell leukemia patient

2002 • 12 citations

Retreatment with 2-CdA of progressed HCL patients.

1994 • 9 citations

One patient's story.

1993 • 3 citations